Immunity to tuberculosis

Annual Review of Immunology

Volumn 22, Issue , 2004, Pages 599-623

  North, Robert J ^a   Jung, Yu Jin ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

CD4 T cells; Interferon ; Lung pathology; Nitric oxide synthase; Th1 immunity

Indexed keywords

BCG VACCINE;

BIOLOGICAL MODEL; CELLULAR IMMUNITY; DISEASE PREDISPOSITION; EXPERIMENTAL INFECTION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETICS; GUINEA PIG; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; INFECTION RESISTANCE; INFECTION SENSITIVITY; LUNG TUBERCULOSIS; MACROPHAGE; MACROPHAGE FUNCTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RABBIT; REVIEW; SYSTEMIC DISEASE; T LYMPHOCYTE; TH1 CELL; TUBERCULOSIS CONTROL; VACCINATION; VIRUS RESISTANCE; VIRUS SURVIVAL;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, NATURAL; MYCOBACTERIUM TUBERCULOSIS; TH1 CELLS; TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 2542480887     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.22.012703.104635     Document Type: Review

References (86)

1. Corbett EL, Watt JC, Walker N, Maher D, Williams BG, et al. 2003. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163:1009-21
2. Mostrom P, Gordon M, Sola C, Ridell M, Rastogi N. 2002. Methods used in molecular epidemiology of tuberculosis. Clin. Microbiol. Infect. 8:694-704
3. Camus JC, Pryor MJ, Medigue C, Cole ST. 2002. Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology 148:2967-73
4. Dannenberg AM. 1989. Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Rev. Infect. Dis. 11(Suppl.)2:S369-78
5. Hill AV. 2001. The genomics and genetics of human infectious disease susceptibility. Annu Rev. Genomics Hum. Genet. 2:373-400
6. Cervino AC, Lackiss S, Sow O, Bellamy R, Beyers N, et al. 2002. Fine mapping of a putative tuberculosis-susceptibility locus on chromosome 15q11-13 in African families. Hum. Mol. Genet. 11:1599-603
7. Marquet S, Schurr E. 2001. Genetics of susceptibility to infectious diseases: tuberculosis and leprosy as examples. Drug Metab. Dispos. 29:479-83
8. Shafer RW, Kim DS, Weiss JP, Quale JM. 1991. Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine 70:384-97
9. Furcolow ML, Hewell B, Nelson WE. 1942. Quantitative studies of the tuberculin reaction: tuberculin sensitivity in relation to active tuberculosis. Am. Rev. Tuberc. 45:504-20
10. Al Zahrani K, Al Jahdali H, Menzies D. 2000. Does size matter? Utility of tuberculin reactions for the diagnosis of mycobacterial disease. Am. J. Respir. Crit. Care Med. 162:1419-22
11. Arend SM, Anderson P, van Meijgaarden KE, Skjot RL, Subronto YW, et al. 2000. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J. Infect. Dis. 181:1850-54
12. Ulrichs T, Anding P, Porcelli S, Kaufmann SH, Munk ME. 2000. Increased numbers of ESAT-6- and purified protein derivative-specific gamma interferon-producing cells in subclinical and active tuberculosis infection. Infect. Immun. 68:6073-76
13. Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, et al. 2001. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am. J. Respir. Crit. Care Med. 163:824-28
14. Chaisson RE, Schecter GF, Theueer CP, Rutherford GW, Echenberg DF, Hopewell PC. 1987. Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am. Rev. Respir. Dis. 136:570-74
15. Casanova J-L, Abel L. 2002. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 20:581-620
16. Medina E, North RJ. 1998. Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype. Immunology 93:270-74
17. North RJ, Medina E. 1998. How important is Nramp1 in tuberculosis? Trends Microbiol. 6:441-43
18. Medina E, North RJ. 1996. Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis. J. Exp. Med. 183:1045-51
19. North RJ, Ryan L, LaCourse R, Mogues T, Goodrich ME. 1999. Growth rate of mycobacteria in mice as an unreliable indicator of mycobacterial virulence. Infect. Immun. 67:5483-85
20. Schell RF, Ealey WF, Harding GE, Smith DW. 1974. The influence of vaccination on the course of experimental airborne tuberculosis in mice. J. Reticuloendothel. Soc. 16:131-38
21. Chackerian AA, Alt JM, Perera TV, Dascher CC, Behar SM. 2002. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect. Immun. 70:4501-9
22. Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ. 2001. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193:271-80
23. Medina E, North RJ. 1999. Genetically susceptible mice remain proportionately more susceptible to tuberculosis after vaccination. Immunology 96:16-21
24. McCune RM, Tompsett R. 1956. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. J. Exp. Med. 104:737-61
25. Mitsos L-M, Cardon LR, Ryan L, LaCourse R, North RJ, Gros P. 2003. Susceptibility to tuberculosis: a locus on mouse chromosome 19 (Tr1-4) regulates Mycobacterium tuberculosis replication in the lungs. Proc. Natl. Acad. Sci. USA 100:6610-15
26. Alsaadi A-I, Smith DW. 1973. The fate of virulent and attenuated mycobacteria in guinea pigs infected by the respiratory route. Am. Rev. Respir. Dis. 107:1041-46
27. Lurie MB, Zappasodi P, Tickner C. 1955. On the nature of genetic resistance to tuberculosis in the light of host-parasite relationships in natively resistant and susceptible rabbits. Am. Rev. Tuberc. Pulm. Dis. 72:297-329
28. Shi L, Jung Y-J, Tyagi S, Gennaro ML, North RJ. 2003. Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence. Proc. Natl. Acad. Sci. USA 100:241-46
29. Dunn PL, North RJ. 1995. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology and cause mortality in mice. Infect. Immun. 63:3428-37
30. Dunn PL, North RJ. 1996. Persistent infection with virulent but not avirulent Mycobacterium tuberculosis in the lungs of mice causes progressive pathology. J. Med. Microbiol. 45:103-9
31. Mitsos L-M, Cardon LR, Fortin A, Ryan L, LaCourse R, et al. 2000. Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice. Genes Immun. 1:467-77
32. Kramnik I, Dietrich WF, Demant P, Bloom BR. 2000. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 97:8560-65
33. Lurie MB, 1932. The correlation between the histological changes and the fate of living tubercle bacilli in the organs of tuberculous rabbits. J. Exp. Med. 55:31-42
34. Smith DW, Harding GE. 1977. Experimental airborne tuberculosis in the guinea pig. Am. J. Pathol. 89:273-76
35. Gehr P, Mwangi DK, Ammann A, Maloiy GM, Taylor CR, Weibel ER. 1981. Design of the mammalian respiratory system. V. Scaling morphometric pulmonary diffusion capacity to body mass: wild and domestic mammals. Respir. Physiol. 44:61-86
36. Sapoval B, Filoche M, Weibel ER. 2002. Smaller is better - but not too small: a physical scale for the design of mammalian pulmonary acinus. Proc. Natl. Acad. Sci USA 99:10411-16
37. Fisler JS, Warden CH. 1997. Mapping of mouse obesity genes: a generic approach to a complex trait. J. Nutr. 127(9):1909S-1916S
38. Sanchez F, Radaeva TV, Nikonenko BV, Persson AS, Sengul S, et al. 2003. Multigenic control of disease after virulent Mycobacterium tuberculosis infection in mice. Infect. Immun. 71:126-31
39. Mackaness GB. 1969. The influence of immunologically commited lymphoid cells on macrophage activity in vivo. J. Exp. Med. 129:973-92
40. Ragno S, Romano M, Howell S, Pappin DJ, Jenner PJ, Colston MJ. 2001. Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transcriptomic and proteomic approach. Immunology 104:99-108
41. Ehrt S, Schnappinger D, Bekiranov S, Drenkow J, Shi S, et al. 2001. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocytic oxidase. J. Exp. Med. 194:1123-40
42. Rook GA, Steele J, Ainsworth M, Leveton C. 1987. A direct effect of glucocorticoid hormones on the ability of human and murine macrophages to control the growth of M. tuberculosis. Eur. J. Respir Dis. 71:286-91
43. Adcock IM. 2001. Glucocorticoidregulated transcription factors. Pulm. Pharmacol Ther. 14:211-19
44. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. 1999. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163:3920-27
45. Means TK, Jones BW, Schromm AB, Shurtleff BA, Smith JA, et al. 2001. Differential effects of Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J. Immunol. 166:4074-82
46. Abel B, Thieblemont N, Quesniaux VJ, Brown N, Mpagi J, et al. 2002. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J. Immunol. 169:3155-62
47. Kamath AB, Alt J, Debbabi H, Behar SM. 2003. Toll-like receptor 4-defective C3H/HeJ mice are not more susceptible than other C3H substrains to infection with Mycobacterium tuberculosis. Infect. Immun. 71:4112-18
48. Reiling N, Holscher C, Fehrenbach A, Kroger S, Kirschning CJ, et al. 2002. Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol. 169:3480-84
49. Boom WH. 1996. The role of T cell subsets in Mycobacterium tuberculosis infection. Infect. Agents Dis. 5:73-81
50. Flynn JL, Chan J. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129
51. Kaufmann SH. 2001. How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol. 1:20-30
52. Boom WH. 1999. γδ T cells and Mycobacterium tuberculosis. Microbes Infect. 1:187-95
53. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. 1993. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-54
54. Cooper AM, Dalton DK, Stewart TA, Griffen JP, Russell DG, Orme IM. 1993. Disseminated tuberculosis in IFN-γ gene-disrupted mice. J. Exp. Med. 178:2243-47
55. Cooper AM, Magram J, Ferrante J, Orme IM. 1997. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186:39-45
56. Jung Y-J, LaCourse R, Ryan L, North RJ. 2002. Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice. Infect. Immun. 70:6436-43
57. Behar SM, Dascher CC, Grusby MJ, Wang CR, Brenner MB. 1999. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 189:1973-80
58. Sousa AO, Mazzaccaro RJ, Russell RG, Lee FK, Turner OC, et al. 2000. Relative contribution of distinct MHC Class I-dependent cell populations in protection to tuberculosis infection in mice. Proc. Natl. Acad. Sci. USA 97:4204-8
59. Rolph MS, Raupach B, Kobernick HH, Collins HL, Perarnau B, et al. 2001. MHC Class Ia-restricted T cells partially account for beta2-microglobulin- dependent resistance to Mycobacterium tuberculosis. Eur. J. Immunol. 31:1944-49
60. -/- mice, but provide minimal protection. J. Immunol. 170:1987-94
61. Schaible UE, Collins HL, Priem F, Kaufmann SH. 2002. Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J. Exp. Med. 196:1507-13
62. Kaufmann SH, Flesch IE. 1988. The role of T cell-macrophage interactions in tuberculosis. Springer Semin. Immunopathol. 10:337-58
63. + lymphocyte responses to pulmonary infection with Mycobacterium tuberculosis in naive and vaccinated BALB/c mice. Tuberculosis 81:327-34
64. Murray HW, Nathan CF. 1999. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J. Exp. Med. 189:741-46
65. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94:5243-48
66. Scanga CA, Mohan VP, Tanaka K, Alland D, Flynn JL, Chan J. 2001. The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice. Infect. Immun. 69:7711-17
67. Jung Y-J, LaCourse R, Ryan L, North RJ. 2002. Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide synthase 2-independent defense in mice. J. Exp. Med. 196:991-98
68. phox47-/- mice. Infect. Immun. 68:1231-34
69. Bodnar KA, Serbina NV, Flynn JL. 2001. Fate of Mycobacterium tuberculosis within murine dendritic cells. Infect. Immun. 69:800-9
70. Tascon RE, Soares CS, Ragno S, Stavopoulos E, Hirst EM, Colston MJ. 2000. Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice. Immunology 99:473-80
71. Goldmann O, Road M, Medina E. 2002. Phagocytosis of bacillus Calmette-Guerin-infected necrotic macrophages induces a maturation phenotype and evokes antigen-presentation function in dendritic cells. Immunology 107:500-6
72. Scanga CA, Mohan VP, Yu K, Joseoh H, Tanaka K, et al. 2000. Depletion of CD4 T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J. Exp. Med. 192:347-58
73. Flynn JL, Scanga CA, Tanaka KE, Chan J. 1998. Effects of aminoguanidine on latent murine tuberculosis. J. Immunol. 160:1796-803
74. Winslow GM, Roberts AD, Blackman MA, Woodland DL. 2003. Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse. J. Immunol. 170:2046-52
75. Hernandez-Pando R, Orozcoe H, Sampieri A, Pavon L, Velasquillo C, et al. 1996. Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology 89:26-33
76. Roach DR, Martin E, Bean AG, Renick DM, Briscoe H, Britton WJ. 2001. Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species. Scand. J. Immunol. 54:163-70
77. Jung Y-J, Ryan L, LaCourse R, North RJ. 2003. Increased interleukin-10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice. Immunology 109:295-99
78. Russell DG. 2001. Mycobacterium tuberculosis: here today, and here tomorrow. Nat. Rev. Mol. Cell Biol. 2:569-77
79. Via LE, Fratti RA, McFalone M, Pagan-Ramos E, Deretic D, Deretic V. 1998. Effects of cytokines on mycobacterial phagosome maturation. J. Cell Sci. 111:897-905
80. Ramachandra L, Noss E, Boom WH, Harding CV. 2001. Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation. J. Exp. Med. 194:1421-32
81. Cappelli G, Volpe P, Sanduzzi A, Sacchi A, Colizzi V, Mariani F. 2001. Human macrophage gamma interferon decreases gene expression but not replication of Mycobacterium tuberculosis: analysis of the host-pathogen reciprocal influence on transcription in a comparison of strains H37Rv and CMT97. Infect. Immun. 69:7262-70
82. Monahan IM, Betts J, Banerjee DK, Butcher PD. 2001. Differential expression of mycobacterial proteins following phagocytosis by macrophages. Microbiology 147:459-71
83. Britton WJ, Palendira U. 2003. Improving vaccines against tuberculosis. Immunol. Cell Biol. 81:34-45
84. Wiegeshaus EH, McMurray DN, Grover AA, Harding GE, Smith DW. 1970. Host-parasite relationships in experimental tuberculosis. Am. Rev. Respir. Dis. 102:422-29
85. van Rie A, Warren R, Richardson M, Victor TC, Gie RP, et al. 1999. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N. Engl. J. Med. 341:1174-79
86. Caminero JA, Pena MJ, Campos-Herrero MI, Rodriguez JC, Afonso O, et al. 2001. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. Am. J. Respir. Crit. Care Med. 163:717-20